Weight is a medical condition, so it deserves a medical plan. Before anything is prescribed, a clinician reads your history and your bloodwork. After that, someone watches how you respond and changes the plan when it needs changing.
At InjectCo MedSpa Woodlands, in Shenandoah on the east side of I-45, nurses run your care and a physician approves it. You decide whether to come in or stay home and use telehealth.
What sets a supervised program apart is what happens around the prescription: screening first, a physician deciding whether treatment is appropriate, and regular follow-up with a nurse who knows your history. When care through your primary care physician or a bariatric program would serve you better, we will tell you.
For background, see the NIDDK overview of prescription medications for overweight and obesity.
No. Compounded semaglutide and compounded tirzepatide are not FDA-approved products. The FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed, the way it reviews an approved drug (FDA).
Compounding has its own federal and state legal framework, and the situations in which a compounder may make copies of commercially available drugs are limited. On April 30, 2026 the FDA proposed not to include semaglutide or tirzepatide on the list of bulk substances that outsourcing facilities may use, because it did not identify a clinical need (FDA announcement). A final decision was still pending when this page was reviewed.
A compounded preparation is not a generic version of an FDA-approved drug, and it has not been shown to work the same way. If one is considered for your treatment, your clinician should explain exactly what is being prescribed, where it comes from and how it differs from an FDA-approved manufactured product. FDA-approved semaglutide and tirzepatide products for chronic weight management also exist, and you can ask your clinician about them.
Our check-ins are not a countdown to the next dose increase. We want to know how you are tolerating the current plan, what side effects have shown up, whether hunger and fullness feel different, and whether your progress is still moving in a direction that makes sense.
A dose change is a clinical decision, not the goal of the program. If you are already responding well, or struggling with side effects, moving higher automatically may not be right for you. Regular follow-up is there to make the medication fit you, not to put every patient on the same ladder.
When a concern falls outside what this program can safely manage, the right next step may be further evaluation, a different treatment plan, or a referral back to your primary care physician or specialist.
Misty, MSN, RN and Lindsey, MSN, APRN, CPNP-AC are the two Clinical Aesthetic Nurse Injectors at our clinic, and they run the program's nurse check-ins. Misty holds a Master of Science in Nursing Leadership and Management and spent 18 years in neonatal intensive care, including time as Neonatal ICU Nurse Manager at Texas Children's Hospital The Woodlands. She also trains new registered nurse injectors for InjectCo. Lindsey is an Advanced Practice Registered Nurse with a Master of Science in Nursing and more than 16 years of direct patient care. Her CPNP-AC is a pediatric acute care nurse practitioner credential. It is not a weight-management or aesthetic certification.
Josh Allen, D.O., InjectCo's Medical Director, reviews eligibility and makes the prescribing decision. Nothing is prescribed until he has reviewed your history and results. His National Provider Identifier is NPI 1982904033. An NPI identifies a provider but does not by itself confirm a license, so you can also check his license with the Texas Medical Board.
Semaglutide is a GLP-1 receptor agonist. FDA-approved semaglutide products have several specific uses depending on the formulation and dose, and one of them is approved for chronic weight management. Tirzepatide acts at both the GIP and GLP-1 receptors, and an FDA-approved tirzepatide product is used for chronic weight management in eligible patients. The NIDDK explains that both act on areas of the brain involved in appetite.
In STEP 1, adults receiving semaglutide 2.4 mg plus a lifestyle program lost about 15% of their body weight on average over 68 weeks (Wilding et al., New England Journal of Medicine, 2021). That result came from a controlled study of the commercially manufactured medication. It should not be assumed to predict results with a compounded preparation or for an individual InjectCo patient.
In SURMOUNT-1, adults without diabetes receiving tirzepatide plus a lifestyle program lost weight at every dose studied over 72 weeks, and the highest dose averaged roughly 20% (Jastreboff et al., New England Journal of Medicine, 2022). That study also used the commercially manufactured medication, and it does not show that a compounded tirzepatide preparation works the same way.
Your clinician decides whether either medicine is appropriate after reviewing your history, labs and goals. For more on each, see tirzepatide in The Woodlands, semaglutide in The Woodlands and oral semaglutide.
A nurse checks in with you every two weeks, at the clinic or by video. We go over how you are feeling, any side effects, how your appetite and fullness have changed, and how your weight is trending. Once a month the plan itself is reviewed.
Medication changes are not automatic, and a monthly review can end with no change at all. The exact medication, concentration and dosing instructions are specific to you. Follow the prescription and measuring instructions that come with your medication, not a dosing schedule you find online.
The prescribing information for the FDA-approved semaglutide and tirzepatide products for weight management is the best guide to what these medicines can do. The most common effects are digestive: nausea, diarrhea, vomiting, constipation and stomach pain or discomfort.
Both labels also warn about less common but serious problems, including inflammation of the pancreas (pancreatitis), gallbladder disease, kidney problems linked to dehydration, severe stomach and bowel reactions, and serious allergic reactions. Low blood sugar is more likely if you also take insulin or certain diabetes medicines. Each label carries its own warnings, including a boxed warning about thyroid C-cell tumors seen in rodents, so your clinician goes through the specific product being considered with you.
Compounded products have not gone through FDA approval and may carry additional quality, concentration or dosing considerations.
The FDA has received reports of dosing errors with compounded injectable semaglutide, some of which needed hospital care (FDA alert). Compounded concentrations can vary, and confusing milligrams, milliliters and syringe “units” can lead to serious mistakes. Use only the dose and measuring instructions for your exact prescription. Do not copy another patient's dose or an online dosing chart.
If a side effect worries you, call or text the clinic at (281) 326-9985 between 8 AM and 7 PM, any day. Do not wait for your next check-in. Go to urgent or emergency care if you cannot keep fluids down, have stomach pain that is severe or will not ease, notice swelling of your face, lips or throat, have trouble breathing, or have any symptom that feels severe. You can also report side effects to the FDA through MedWatch.
General criteria for FDA-approved chronic weight-management medicines, which the NIDDK also describes, cover adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition. Meeting a threshold does not make a prescription automatic. Your history, your current medicines and the specific product being considered still matter.
Our screening draws on the established safety information for these active ingredients and on our own clinical protocol, so the list below is not the only thing we consider. If medication is not right for you, we will point you toward your primary care physician or a bariatric program instead.
$425 a month covers what happens around a prescription, not just the medicine: medical screening, the lab work your clinician orders for the program, the prescribing review, nurse check-ins every two weeks, monthly plan reviews, and medication when it is prescribed. The $1,800 option covers the same services for a 6 to 8 month program, paid once.
The program is self-pay. HSA and FSA cards may be accepted for eligible expenses. Plan rules vary, so confirm eligibility with your plan administrator.
The next step depends on the medication, your health history, how you have responded and the prescribing clinician's plan. Some patients continue treatment, some adjust their plan, and some move to another way of maintaining their weight.
Weight regain can happen after medication is stopped. The NIDDK notes that you will probably regain some weight when you stop taking a weight management medicine, so nutrition, activity and medical follow-up still matter over the long term. We plan this with you before you reach your goal, not after.
InjectCo MedSpa Woodlands is at 250 Ed English Dr #3D. That postal address is in the city of Shenandoah, on the east side of I-45 beside The Woodlands, and we serve The Woodlands and the surrounding communities from here. The clinic is in the Portofino Plaza office condominiums, beside the Portofino Plaza shops and just north of Sam's Club. Memorial Hermann The Woodlands Medical Center is about 1.5 miles away; if you already see a doctor nearby, bring your medication list to your first visit.
Consultations and check-ins can happen here or by video, whichever suits you. Patients come from across The Woodlands, from Spring, Oak Ridge North and Conroe, and from nearby communities.
Mon to Sun, 8:00 AM to 7:00 PM
Our clinic holds 5.0 on Google from 170 reviews. These come from patients across every treatment at our clinic, not only weight loss, quoted exactly as they wrote them. Individual results vary.
$425 a month for screening, program labs, the prescribing review, check-ins, monthly plan reviews and medication when prescribed. The $1,800 option covers the same services for 6 to 8 months, paid once.
Many clinics use the two terms interchangeably. Our program covers both: the active phase, when you are losing weight with nurse check-ins every two weeks, and the planning for how you will maintain your weight once you reach your goal or stop medication.
Consultations and check-ins can be in person or by video. Ask the clinic how your lab work will be arranged if you are not coming in.
Your plan is overseen by a physician. Josh Allen, D.O., InjectCo's Medical Director, reviews your history and results and makes the prescribing decision. Your visits and check-ins are with our nurses, Misty, MSN, RN and Lindsey, MSN, APRN, CPNP-AC, at the Shenandoah clinic or by video.
A nurse asks how you are feeling, which side effects you have noticed, how your appetite and fullness have changed and how your weight is trending. If something points to a change in your plan, that decision goes to the prescribing clinician.
No. The monthly review looks at how you are tolerating the medication and how you are responding. It may end with no change at all. Any change is a clinical decision made for you, not a fixed schedule.
Tell us about any side effect that worries you. Call or text (281) 326-9985 promptly about vomiting or diarrhea that will not settle, or severe stomach pain. Get emergency care for trouble breathing or swelling of the face, lips or throat.
The trials measured average results with commercially manufactured medication under controlled conditions. They do not predict what a compounded preparation will do, or what any one person will lose.
Your clinician plans the next step with you before you get there. See the goal weight section above.
No. Compounded versions are not FDA-approved and are not generic copies of approved drugs. Your clinician will explain exactly what is prescribed and where it comes from.
A compounder registered with the FDA under section 503B of the Federal Food, Drug, and Cosmetic Act. Registration is not FDA approval of its products. You can ask which facility or pharmacy prepared your medication.
The clinic at 250 Ed English Dr #3D sits in the city of Shenandoah, on the east side of I-45 next to The Woodlands. Patients come from The Woodlands, Spring, Oak Ridge North, Conroe and nearby communities, and check-ins can also be done by video.
His National Provider Identifier is 1982904033, listed in the CMS NPI Registry for Joshua Allen, D.O., in Texas. An NPI identifies a provider but does not by itself prove licensure, so you can also check his license on the Texas Medical Board website.
Every patient starts the same way. You complete a screening, your bloodwork is done, and a physician reviews it before anything is prescribed.
Last medically reviewed: September 20, 2026, by Josh Allen, D.O., Medical Director, InjectCo MedSpa.
This page is general information about the program, not medical advice for your situation. Results vary. If you have a reaction to a medication, call or text the clinic at (281) 326-9985 or get urgent care, and you can report side effects to the FDA through MedWatch.
Medically reviewed by Dr. Josh Allen, D.O., Medical Director, InjectCo MedSpa.
